Video

Q&A With David Shavelle, MD, From the University of Southern California: Updating the Guidelines for Acute Coronary Syndromes

Author(s):

As new medications and agents are developed organizations like the American College of Cardiology and the American Heart Association update their guidelines on treating a variety of conditions. Recently work was completed to help doctors treating acute coronary syndromes.

As new medications and agents are developed organizations like the American College of Cardiology and the American Heart Association update their guidelines on treating a variety of conditions. Recently work was completed to help doctors treating acute coronary syndromes.

David Shavelle, MD, from the University of Southern California discussed what the new guidelines mean for treatment and also some new medications that doctors can prescribe their patients during the American College of Physicians Internal Medicine meeting in Boston. Shavelle said in some cases the new medications could be used instead of the more commonly used and popular clopidogrel even as further studies are conducted.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.